The utility of post-void residual volume versus sphincter electromyography to distinguish between multiple system atrophy and Parkinson’s disease
Objective: To determine the ability of sphincter electromyography (EMG) and post-void residual urine volume (PVR) during a free-flow study and a pressure-flow study (PFS) for…Cerebrospinal Fluid Levels of Coenzyme Q10 are Reduced in Multiple System Atrophy
Objective: To assess CSF levels of coenzyme Q10 in multiple system atrophy (MSA) vs. Parkinson’s disease (PD), progressive supranuclear palsy (PSP), and control subjects without…Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy
Objective: We aimed to develop AAV-based models of MSA Background: Multiple system atrophy (MSA) is a fatal neurodegenerative disorder characterized by a combination of autonomic…The predictor factors for survival in Chinese Multiple System Atrophy patients
Objective: Our aim was to explore the predictors of survival in Chinese multiple system atrophy (MSA) patients. Background: MSA is a rare, fatal neurodegenerative disorder with…Depression, anxiety and quality of life in Multiple System Atrophy
Objective: To explore the features and determinants of depression and anxiety symptoms in multiple system atrophy (MSA) and the associations between mood dysfunction and quality…α-Synuclein Preformed Fibrils Induce Disruption of Myelin Basic Protein Expression in Primary Oligodendrocyte Culture; Deciphering Glial Pathology in Multiple System Atrophy
Objective: This research focuses on the impact of extracellular α-synuclein preformed fibrils (α-syn PFFs) on oligodendrocytes (OLGs) as a potential contributor exacerbating the pathology of…Profound reduction of DAT-SPECT signal in multiple system atrophy (MSA)
Objective: To evaluate the extent of degeneration in dopamine nerve terminal in striatum in the patients with MSA-P and MSA-C, and to compare the progression…Can the level of CSF Neurofilament Light Chain predict disease progression in Progressive Supranuclear Palsy?
Objective: To investigate whether the level of CSF Neurofilament Light Chain (NFL) can predict the speed of disease progression in patients with Progressive Supranuclear Palsy…Differential diagnosis of Parkinson’s Disease and Progressive Supranuclear Palsy
Objective: The description of differential diagnostic features of PSP and PD in order to improve the diagnosis and the differential diagnosis of these diseases. Background:…Evaluation of a Radiographic Marker as a Diagnostic Tool For Progressive Supranuclear Palsy
Objective: To evaluate the sensitivity and specificity of a radiographic marker, midbrain to pons ratio, in brain MRI of Progressive Supranuclear Palsy (PSP) patients as…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.